
Israel Innovation Authority
Description
The Israel Innovation Authority (IIA) stands as the central governmental agency responsible for fostering industrial R&D and innovation within Israel. Unlike traditional venture capital firms, the IIA operates by providing non-dilutive financial support, primarily in the form of grants, to a wide spectrum of companies and research institutions. Its core mission is to strengthen Israel's innovation ecosystem, maintain its competitive edge as a 'Start-up Nation,' and address national challenges through technological advancement. The Authority plays a crucial role in de-risking early-stage and high-risk R&D projects, thereby encouraging private sector investment and promoting economic growth.
The IIA manages a diverse portfolio of programs tailored to different stages of technological development and company needs. These include initiatives for pre-seed ideas (like the Tnufa program), support for R&D in established companies, pilot programs for mature technologies, and international collaboration frameworks. The grants typically cover a percentage of approved R&D expenses, varying by program and project type, and are designed to accelerate the development of groundbreaking technologies and products. This strategic funding mechanism helps Israeli companies bridge funding gaps and bring innovative solutions to market.
The Authority's impact is substantial, underpinned by a significant annual budget. For instance, in 2023, the Israel Innovation Authority operated with an annual budget of approximately NIS 2.2 billion (over $600 million USD), demonstrating the government's commitment to innovation. This funding enables the IIA to support a vast number of R&D initiatives; in 2022 alone, it approved support for over 1,000 R&D programs across various sectors. By providing this critical financial backing, the IIA not only stimulates technological breakthroughs but also helps create high-quality jobs and strengthens Israel's position as a global leader in innovation.
Investor Profile
Israel Innovation Authority has backed more than 43 startups, with 19 new investments in the last 12 months alone. The firm has led 16 rounds, about 37% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Seed, Pre Seed rounds (top funding stages).
- Majority of deals are located in Israel, United States, The Netherlands.
- Strong thematic focus on Artificial Intelligence (AI), Medical Device, Health Care.
- Led 13 rounds in the past year.
- Typical check size: $100K – $1.5M.
Stage Focus
- Grant (51%)
- Seed (33%)
- Pre Seed (7%)
- Series A (7%)
- Post Ipo Equity (2%)
Country Focus
- Israel (79%)
- United States (14%)
- The Netherlands (5%)
Industry Focus
- Artificial Intelligence (Ai)
- Medical Device
- Health Care
- Biotechnology
- Software
- Information Technology
- Medical
- Drones
- Health Diagnostics
- Agtech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.